Page 21 - GP fall 2023
P. 21

poor glycemic control compared to patients  Treatment  decisions  should  be  made  on  a   10. Tan SJ, Baharin B, Nabil S, Mohd N, Zhu
      with  good  glycemic  control;  however,  the  case-by-case  basis  considering  all  patient   Y.  Does  Glycemic  Control  Have  A  Dose-Re-
      clinical  benefit  is  low  because  there  are  a  factors. Ultimately the final treatment is the   sponse  Relationship  With  Implant  Outcomes?
      series of health consequences as a result of  patient’s choice. Still, it is critical that the   A  Comprehensive  Systematic  Review  And
      uncontrolled diabetes. It is in the patient’s  patient is informed about the importance of   Meta-Analysis.  J  Evid  Based  Dent  Pract.
                                                                                 2021  Jun;21(2):101543.  doi:  10.1016/j.jeb-

      best interest to control their glycemic level  diabetes control and is encouraged to man-  dp.2021.101543.  Epub  2021  Mar  6.  PMID:
      before considering implant placement.  age their Type 2 diabetes.          34391557.
                                                                                 11. Shi Q, Xu J, Huo N, Cai C, Liu H. Does a
      Discussion                            References                           higher  glycemic  level  lead  to  a  higher  rate  of
      The  evidence  is  from  three  systematic  re-  1. Pandey A, Chawla S, Guchhait P. Type-2 di-  dental  implant  failure?: A  meta-analysis.  J Am
      views, two with good methodological quali-  abetes:  Current  understanding  and  future  per-  Dent  Assoc.  2016  Nov;147(11):875-881.  doi:
      ty and one with moderate quality. The three   spectives. IUBMB Life. 2015 Jul;67(7):506-13.   10.1016/j.adaj.2016.06.011.  Epub  2016  Jul  18.
      reviews  included  cross-sectional  studies   doi: 10.1002/iub.1396. Epub 2015 Jul 15. PMID:   PMID: 27435008.
      and retrospective and prospective studies -   26177573.                    12.  Oates  TW,  Huynh-Ba  G,  Vargas  A,  Alex-
                                            2. Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami
      mostly cohort studies, the appropriate study   R. Type 2 Diabetes and its Impact on the Immune   ander P,  Feine J. A  critical review of  diabetes,
      design for clinical questions related to prog-  System. Curr Diabetes Rev. 2020;16(5):442-449.     glycemic  control,  and  dental  implant  therapy.
                                                                                 Clin  Oral  Implants  Res.  2013  Feb;24(2):117-
      nosis.  Most  of  the  included  studies  have   doi: 10.2174/1573399815666191024085838 PMID:     27.  doi:  10.1111/j.1600-0501.2011.02374.x.
      moderate to high bias risk and were exclud-  31657690; PMCID: PMC7475801.   Epub 2011 Nov 24. PMID: 22111901; PMCID:
      ed through the appraisal process. For exam-  3.  Viigimaa  M,  Sachinidis  A,  Toumpourleka   PMC3329564.
      ple, Oates et al. 2013 focused on only three   M, Koutsampasopoulos K, Alliksoo S, Titma T.
      out of the 16 studies because they were the   Macrovascular Complications of Type 2 Diabetes   Liana Umbrio is a den-
      only studies that had acceptable documen-  Mellitus. Curr Vasc Pharmacol. 2020;18(2):110-  tal student in the class of
      tation  of  glycemic  control.  However,  the   116. doi: 10.2174/157016111766619040516515  2025 at NYU College of
      studies that did use HbA1C values had other   1. PMID: 30961498.                          Dentistry.
                                            4. Bin Rakhis SA Sr, AlDuwayhis NM, Aleid N,
      limitations. Shi et al. 2016 reviewed studies   AlBarrak AN, Aloraini AA.  Glycemic  Control
      where  the  glycemic  levels  of  the  patients   for Type 2 Diabetes Mellitus Patients: A System-
      overlapped: levels were less than 8% in pa-  atic Review. Cureus. 2022 Jun 21;14(6):e26180.
      tients with well-controlled diabetes, and the   doi:  10.7759/cureus.26180.  PMID:  35891859;
      levels ranged from 7% to 13.8% in patients   PMCID: PMC9304683.                           Gary Berkowitz,  DDS,
      with diabetes that were not well-controlled.   5. Sherwani SI, Khan HA, Ekhzaimy A, Masood   is a Clinical  Associate
      Also,  the  methods  of  evaluating  glycemic   A, Sakharkar MK. Significance of HbA1c Test   Professor in the Depart-
      levels  were  inconsistent:  the  investigators   in Diagnosis and Prognosis of Diabetic Patients.   ment  of  Cariology  and
      of six studies used HbA1c, and the investi-  Biomark  Insights.  2016  Jul  3;11:95-104.  doi:   Comprehensive  Care, a
      gators of one study used FPG. Lastly, Tan et   10.4137/BMI.S38440.  PMID:  27398023;  PM-  senior  mentor  at  NYU
                                            CID: PMC4933534.
      al. 2021 only used baseline HbA1c values.   6. Preshaw PM, Bissett SM. Periodontitis and di-  College of Dentistry, and
      Still,  since  glycemic  control  is  a  dynam-  abetes. Br Dent J. 2019 Oct;227(7):577-584. doi:   Group Practice Director.
      ic value, it was assumed that each patient   10.1038/s41415-019-0794-5. PMID: 31605062.
      remained  in  the  same  category  of  control   7. Weijdijk LPM, Ziukaite L, Van der Weijden   Analia Veitz-Keenan, DDS,
      throughout the study period. No statistically   GAF, Bakker EWP, Slot DE. The risk of tooth   is a Clinical Professor in
      significant results were found, and only one   loss in patients with diabetes: A systematic re-  the  Department  of  Oral
      systematic review actually measured statis-  view  and  meta-analysis.  Int  J  Dent  Hyg.  2022   Maxillofacial Pathology,
      tical significance between the studies.   Feb;20(1):145-166.  doi:  10.1111/idh.12512.   Radiology and Medicine,
                                            Epub 2021 Aug 24. PMID: 33973353; PMCID:           and Epidemiology and
      Despite  the  fact  that  implants  may  fail  at   PMC9291053.                          Health  Promotion  at  NYU
      similar  rates  in  people  with  diabetes  with   8. Naujokat H, Kunzendorf B, Wiltfang J. Dental   College of Dentistry. She is the current
                                            implants and diabetes mellitus-a systematic re-
      good  glycemic  control  and  poor  glycemic   view. Int J Implant Dent. 2016 Dec;2(1):5. doi:   NYSAGD President-elect.
      control,  there  are  still  many  other  health   10.1186/s40729-016-0038-2. Epub 2016 Feb 11.
      consequences  that  follow  being  an  un-  PMID: 27747697; PMCID: PMC5005734.
      controlled  diabetic.  These  consequences   9. Misch CE, Perel ML, Wang HL, Sammarti-
      include  hyperglycemia  and  metabolic  aci-  no G, Galindo-Moreno P, Trisi P, Steigmann M,
      dosis, increased risk of infections, delayed   Rebaudi A, Palti A, Pikos MA, Schwartz-Arad
      wound healing, and micro- and macrovas-  D,  Choukroun  J,  Gutierrez-Perez  JL,  Maren-
      cular complications. Patients should always   zi G, Valavanis DK. Implant success, survival,
      be encouraged to control their diabetes, and   and  failure:  the  International  Congress  of  Oral
      despite research showing implants can suc-  Implantologists  (ICOI)  Pisa  Consensus  Con-
                                            ference.  Implant  Dent.  2008  Mar;17(1):5-15.
      ceed in patients with poor glycemic control,   doi:  10.1097/ID.0b013e3181676059.  PMID:
      it may not be the case for every patient, even   18332753.
      patients with reasonable glycemic control.











                                                                                      www.nysagd.org l Fall 2023 l GP 21
   16   17   18   19   20   21   22   23   24   25   26